Back to search

Article

Blood transcriptomics identifies FEZ1 as a novel non-invasive diagnostic biomarker for inflammatory bowel disease

2024-10-28

Abstract excerpt

<title>Abstract</title> <p>In comparison with conventional diagnostic methods, blood biomarkers are an easily accessible source for diagnosing inflammatory bowel disease (IBD). To identify such a biomarker, an integrated transcriptomics approach was employed to detect RNAs exhibiting diagnostic efficacy. For this purpose, four gene expression datasets obtained from blood specimens were integrated (GSE119600, GSE9...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
99a50826-1523-5654-9152-3a33b38c0d1c
DOI
10.21203/rs.3.rs-5255906/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Blood transcriptomics identifies FEZ1 as a novel non-invasive diagnostic biomarker for inflammatory bowel diseaseDOI 10.21203/rs.3.rs-5255906/v1
Select a neighboring publication to make it the new centre.